Erste Asset Management’s Global Blood Therapeutics, Inc. GBT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-58,000
| Closed | -$3.95M | – | 973 |
|
|
2022
Q3 | $3.95M | Hold |
58,000
| – | – | 0.09% | 225 |
|
|
2022
Q2 | $1.87M | Hold |
58,000
| – | – | 0.04% | 287 |
|
|
2022
Q1 | $2.03M | Buy |
58,000
+4,500
| +8% | +$157K | 0.04% | 293 |
|
|
2021
Q4 | $1.62M | Hold |
53,500
| – | – | 0.03% | 315 |
|
|
2021
Q3 | $1.38M | Hold |
53,500
| – | – | 0.03% | 309 |
|
|
2021
Q2 | $1.74M | Hold |
53,500
| – | – | 0.03% | 297 |
|
|
2021
Q1 | $2.18M | Hold |
53,500
| – | – | 0.05% | 259 |
|
|
2020
Q4 | $2.36M | Hold |
53,500
| – | – | 0.07% | 244 |
|
|
2020
Q3 | $2.89M | Hold |
53,500
| – | – | 0.1% | 204 |
|
|
2020
Q2 | $3.56M | Hold |
53,500
| – | – | 0.14% | 162 |
|
|
2020
Q1 | $2.78M | Sell |
53,500
-10,300
| -16% | -$536K | 0.16% | 153 |
|
|
2019
Q4 | $5.05M | Hold |
63,800
| – | – | 0.22% | 110 |
|
|
2019
Q3 | $3.14M | Hold |
63,800
| – | – | 0.17% | 138 |
|
|
2019
Q2 | $3.44M | Buy |
63,800
+34,800
| +120% | +$1.88M | 0.18% | 129 |
|
|
2019
Q1 | $1.51M | Buy |
29,000
+13,000
| +81% | +$676K | 0.08% | 204 |
|
|
2018
Q4 | $638K | Buy |
+16,000
| New | +$638K | 0.04% | 274 |
|